Síguenos en Twitter     Síguenos en Facebook     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Dropbox     Instagram     Google Drive     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon

SOBRE EL AUTOR **

My photo
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com

WORLD EMERGENCY MEDICINE SOCIETIES & RELATED

Search

Content:

Tuesday, August 17, 2021

Cannabinoid Hyperemesis Syndrome

canadiEM - By Harrish Gangatharan - August 17, 2021
Take Home Points
  1. Think of marijuana use when seeing young adults with abdominal pain. Majority of marijuana related hospitalizations exclusively occur in the young adult population 15-25 years old. 
  2. Significant stigma and reluctance to admit any cannabinoid use is a common characteristic of cannabinoid hyperemesis syndrome.
  3. Cannabinoid hyperemesis syndrome and cyclical vomiting syndrome are similar and sometimes temporally linked syndromes.
  4. Edible cannabis products can still be associated with cannabinoid hyperemesis syndrome. 
  5. Low dose haloperidol < 2 mg IV can be safely used with cannabinoid hyperemesis syndrome.